Britain’s GlaxoSmithKline and France’s Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate and aim to reach the final testing stage in…

Read more »

The post GSK, Sanofi Begin New COVID-19 Vaccine Trial After Setback appeared first on Hamodia.

In related news:

  1. Global Death Toll From COVID-19 Passes 400,000
  2. Australia Says COVID-19 Outbreak Shows Signs of Peaking
  3. Dutch, Belgian Patients Reinfected With Coronavirus
  4. Novacyt Launches Test to Differentiate COVID-19 and Flu
  5. U.K. Says COVID-19 Booster and Annual Vaccinations ‘Very Probable’